The FDA approved tezepelumab-ekko (TEZSPIRE; AstraZeneca/Amgen) on Friday as an add-on maintenance treatment in patients aged ...
The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.
Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP ...
Amgen and AstraZeneca’s Tezspire (tezepelumab-ekko) gains FDA approval as an add-on maintenance therapy for patients aged 12 and older with inadequately controlled chronic rhinosinusitis with nasal ...
October 2025 Tezspire approved in the US for chronic rhinosinusitis with nasal polyps Approval broadens indication for Tezspire to a second disease characterised by epithelial-driven inflammationAstra ...
At the LifeBridge Health ENT Sinus & Allergy Center, Dr. Alpen Patel helps patients get to the root of disrupted sleep. With ...
Northwell Health has opened Northwell Health Physician Partners (NHPP) Otolaryngology at 244 Westchester Ave. in White Plains. The 3,000-square-foot facility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback